Bleeding, Hyponatremia, and Discontinuation Risks

One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners.

References:

• https://pmc.ncbi.nlm.nih.gov/articles/PMC4428540/

  https://pubmed.ncbi.nlm.nih.gov/10333979⁠

  ⁠https://pmc.ncbi.nlm.nih.gov/articles/PMC3663330/⁠